Clinical Trial

Magnesium-Titanium Hybrid Intramedullary Nail System For Long Bone Fractures

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective, multicenter, randomized, controlled, non-inferiority clinical trial designed to evaluate the safety and effectiveness of the magnesium-titanium hybrid intramedullary nail system compared with the marketed metal locked intramedullary nail in the treatment of long bone fractures of the extremities.
Trial Details
NCT Number NCT07569575
Lead Sponsor HuaMg Perfection Med Tech (Suzhou) Co., Ltd.
Conditions Tibial Fracture, Femoral Fracture, Humeral Fracture
Enrollment 160 participants
Start Date 2026-05-01
Primary Completion 2027-03-29 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-06